McGuire Investment Group, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
McGuire Investment Group, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,062,000
-29.9%
228,810
-6.9%
0.39%
-30.5%
Q2 2021$2,941,000
-14.0%
245,718
-9.9%
0.56%
-22.6%
Q1 2021$3,418,000
+615.1%
272,801
+789.9%
0.72%
+511.0%
Q4 2020$478,000
+133.2%
30,655
+41.2%
0.12%
+93.4%
Q3 2020$205,000
+0.5%
21,710
-4.8%
0.06%
-14.1%
Q2 2020$204,000
+46.8%
22,800
+4.6%
0.07%
+22.4%
Q1 2020$139,000
-20.1%
21,800
+4.8%
0.06%
+11.5%
Q4 2019$174,000
+58.2%
20,800
+71.9%
0.05%
+44.4%
Q3 2019$110,00012,1000.04%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders